The webinar includes discussion of the latest European biotech patent case law developments including clinical trials protocols as prior art:

• T 1123/16 (Eosinophilic bronchitis/GLAXO)
• T 2963/19 (Liposomal irinotecan/IPSEN)
• T 108/21 (Treatment of multiple sclerosis/NOVARTIS)

And sufficiency of antibody claims:

• T 2416/18 (Cross-neutralising antibodies/POMANA RICERCA)
• T 317/20 (NGF antagonist for treatment of osteoarthritis/RINAT)
• T 499/18 (Compositions and methods for treating cancer/ONCOMED)

System requirements

To view our webinars we recommend the following internet browsers:

• Google Chrome (most recent 2 versions).
• Mozilla Firefox (most recent 2 versions).
• Apple Safari (most recent 2 versions).
• Microsoft Edge (most recent 2 versions).